86 related articles for article (PubMed ID: 1530322)
1. [Intrapleural treatment of breast cancer patients with pleural effusions: an analysis of 13 institutes in Kyoto and Shiga Prefectures. Kyoto and Shiga Breast Cancer Study Group].
Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Ohsumi K; Kudo N; Mukaihara S
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1632-5. PubMed ID: 1530322
[TBL] [Abstract][Full Text] [Related]
2. [Intrapleural administration with OK-432 and cultured autologous pleural effusion lymphocytes for breast cancer patients with malignant pleural effusions: analysis of 84 patients over a 14-year period].
Kan N
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1796-800. PubMed ID: 10560397
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural adaptive immunotherapy for breast cancer patients with cytologically-confirmed malignant pleural effusions: an analysis of 67 patients in Kyoto and Shiga Prefecture, Japan.
Kan N; Kodama H; Hori T; Takenaka A; Yasumura T; Kato H; Ogawa H; Mukaihara S; Kudo T; Ohsumi K
Breast Cancer Res Treat; 1993 Sep; 27(3):203-10. PubMed ID: 8312578
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
Kan N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
[TBL] [Abstract][Full Text] [Related]
5. [Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor].
Kan N; Harada T; Kodama H; Ichinose Y; Moriguchi Y; Sugie T; Li L; Sato K; Imamura M
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1593-6. PubMed ID: 8373227
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
Kono K; Takahashi A; Ichihara F; Amemiya H; Iizuka H; Fujii H; Sekikawa T; Matsumoto Y
Clin Cancer Res; 2002 Jun; 8(6):1767-71. PubMed ID: 12060615
[TBL] [Abstract][Full Text] [Related]
7. [A case of breast cancer with pleural metastasis responding to administration of intrapleural adriamycin and systemic chemotherapy with FEMP].
Ogasahara K; Takeda R; Nishizawa F; Yoshimura T; Denno R; Adachi Y; Takahashi J; Kohno Y; Bada K; Ohbayashi M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3140-2. PubMed ID: 3118815
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
Kan N
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of intrapleural or peritoneal administration of lentinan and OK-432 for malignant effusion].
Kawaoka T; Yoshino S; Hazama S; Tangoku A; Oka M
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1562-5. PubMed ID: 14619464
[TBL] [Abstract][Full Text] [Related]
10. Pleural effusion in breast cancer: influence upon clinical course and survival.
Singer TS; Sulkes A; Biran S
Chemioterapia; 1986 Feb; 5(1):66-9. PubMed ID: 3955787
[TBL] [Abstract][Full Text] [Related]
11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
12. [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion].
Fukuoka M; Takada M; Tamai S; Negoro S; Matsui K; Ryu S; Sakai N; Sakaguchi K
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1543-9. PubMed ID: 6206796
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
14. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
15. [Retrospective analysis of 98 cases of breast cancer with liver metastasis].
Zhu MQ; Zhang DS; Su ZY; Shi YX; Peng RJ; Zhou NN; Liu DG; Jiang WQ
Ai Zheng; 2007 Apr; 26(4):423-6. PubMed ID: 17430666
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer.
Inoue K; Ogawa M; Horikoshi N; Aiba K; Mukaiyama T; Mizunuma N; Itami S; Hirano A; Matsuoka A; Matsumura T
Jpn J Clin Oncol; 1991 Oct; 21(5):334-9. PubMed ID: 1753413
[TBL] [Abstract][Full Text] [Related]
17. Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters.
Stathopoulos GP; Baxevanis CN; Papadopoulos NG; Zarkadis IK; Papacostas P; Michailakis E; Tsiatas ML; Papamichail M
Anticancer Res; 1996; 16(6B):3855-60. PubMed ID: 9042270
[TBL] [Abstract][Full Text] [Related]
18. p53 as a specific prognostic factor in triple-negative breast cancer.
Chae BJ; Bae JS; Lee A; Park WC; Seo YJ; Song BJ; Kim JS; Jung SS
Jpn J Clin Oncol; 2009 Apr; 39(4):217-24. PubMed ID: 19304743
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study.
Yoshida M; Ohtsu A; Boku N; Miyata Y; Shirao K; Shimada Y; Hyodo I; Koizumi W; Kurihara M; Yoshida S; Yamamoto S
Jpn J Clin Oncol; 2004 Nov; 34(11):654-9. PubMed ID: 15613554
[TBL] [Abstract][Full Text] [Related]
20. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect].
Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]